China Resources Medical Holdings Company Limited Cash Flow-to-Debt Ratio
China Resources Medical Holdings Company Limited cash flow-to-debt ratio. China Resources Medical Holdings Company Limited (1PH) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2023, meaning its operating cash flow of €270.22 Million could theoretically repay 0% of its total liabilities (€11.33 Billion) in one year. Check cash flow quality index of China Resources Medical Holdings Company to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of China Resources Medical Holdings Company Limited (2016–2025)
Cash flow-to-debt ratio of China Resources Medical Holdings Company Limited from 2016 to 2025. Historical debt coverage capacity for China Resources Medical Holdings Company Limited across 10 annual periods. Check China Resources Medical Holdings Company (1PH) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
China Resources Medical Holdings Company Limited Cash Flow-to-Debt Ratio by Year (2016–2025)
China Resources Medical Holdings Company Limited cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for China Resources Medical Holdings Company Limited. For the full cash flow conversion analysis, see how efficiently does China Resources Medical Holdings Company generate cash.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | €1.36 Billion | €5.03 Billion | ▲ +23.8% |
| 2024 | 0.22x | €1.27 Billion | €5.82 Billion | ▲ +21.3% |
| 2023 | 0.18x | €1.20 Billion | €6.64 Billion | ▲ +17.9% |
| 2022 | 0.15x | €626.58 Million | €4.11 Billion | ▼ -22.2% |
| 2021 | 0.20x | €710.43 Million | €3.62 Billion | ▼ -20.1% |
| 2020 | 0.25x | €643.69 Million | €2.62 Billion | ▲ +16.2% |
| 2019 | 0.21x | €366.05 Million | €1.73 Billion | ▲ +1.7% |
| 2018 | 0.21x | €334.15 Million | €1.61 Billion | ▼ -40.7% |
| 2017 | 0.35x | €459.54 Million | €1.31 Billion | ▲ +70.6% |
| 2016 | 0.21x | €223.79 Million | €1.09 Billion | — |